Article
Hematopoietic fitness of <i>JAK2<sup>V617F</sup></i> Myeloproliferative Neoplasms is linked to clinical outcome
2021-02-01
Abstract excerpt
Myeloproliferative Neoplasms (MPN) harbor highly recurrent driver mutations affecting targetable kinases yet treatment options for these phenotypically diverse diseases are limited, and patients experience significant morbidity and shortened survival. The most important disease-related complications—thrombosis, transformation and death—are not used as clinical trial endpoints due to the long follow-up required to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b1e38acb-8d67-5f2a-b842-73fe3249c90c
- DOI
- 10.1101/2021.01.28.21250575
